Zhu et al. [25] demonstrated in a rat model of surgically induced endometriosis that oral administration of ketotifen (a mast-cell stabilizer and HRH1 antagonist) significantly suppressed the development of hyperalgesia, likely by reducing mast-cell activity within lesions and thereby dampening peripheral sensitization. Here, HRH1 is linked to endometriosis.